Valuation: 10x Genomics, Inc.

Market Cap 10.03B 8.73B 8.27B 7.51B 14.03B 960B 14.1B 98.47B 38.07B 488B 37.67B 36.83B 1,563B P/E 2026 *
-107x
P/E 2027 * -111x
Enterprise Value 9.56B 8.33B 7.88B 7.16B 13.38B 916B 13.45B 93.9B 36.31B 465B 35.93B 35.13B 1,490B EV / Sales 2026 *
15.4x
EV / Sales 2027 * 14x
Free-Float
90.92%
Yield 2026 *
-
Yield 2027 * -
1 day+5.90%
1 week+15.95%
Current month+23.25%
1 month+32.73%
3 months+139.56%
6 months+325.48%
Current year+371.92%
1 week 64.73
Extreme 64.73
79.94
1 month 57.83
Extreme 57.83
79.94
Current year 15.9
Extreme 15.9
79.94
1 year 11.16
Extreme 11.16
79.94
3 years 6.78
Extreme 6.78
79.94
5 years 6.78
Extreme 6.78
187.85
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/9/26 Sell

Chief Financial Officer

-46,388 0.0386%
9/3/26 Sell

Chairman

-20,000 0.0166%
9/1/26 Don

Founder

-100 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+5.90%+15.95%+498.52%+54.78% 9.47B
+4.69%+15.14%+220.16%+520.05% 23.47B
-0.48%+0.70%-36.53%-21.55% 9.84B
+9.61%+28.62%-7.78% - 7.97B
+0.26%+0.41%+98.27%+55.53% 6.56B
+0.22%+1.87%-29.50%-24.49% 5.74B
+1.30%+3.61%-3.12%-17.22% 4.3B
+0.95%-3.17%+53.60%+64.65% 3.74B
+0.78%+0.09%-21.43%-30.67% 2.72B
-1.66%-14.85% - - 1.57B
Average +2.16%+6.17%+85.80%+75.13% 7.54B
Weighted average by Cap. +3.31%+7.79%+136.44%+194.73%

Financials

2026 *2027 *
Net sales 620M 540M 511M 464M 868M 59.38B 872M 6.09B 2.35B 30.18B 2.33B 2.28B 96.61B 680M 592M 561M 509M 952M 65.13B 956M 6.68B 2.58B 33.1B 2.55B 2.5B 106B
Net income -94.29M -82.13M -77.73M -70.62M -132M -9.03B -133M -926M -358M -4.59B -354M -346M -14.69B -88.67M -77.23M -73.09M -66.41M -124M -8.49B -125M -871M -337M -4.32B -333M -326M -13.82B
Net Debt -465M -405M -383M -348M -651M -44.53B -654M -4.57B -1.77B -22.63B -1.75B -1.71B -72.45B -521M -454M -429M -390M -729M -49.89B -732M -5.11B -1.98B -25.35B -1.96B -1.91B -81.17B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems. Its products are used across diverse fields, from cancer research and immunology to neuroscience and developmental biology. Its commercial product portfolio is made up of its Single Cell and Spatial solutions. Its products include its instruments, which include its Chromium instruments, its Visium CytAssist and its Xenium Analyzer, and its consumables, which include proprietary microfluidic chips, slides, reagents and other consumables for its Single Cell and Spatial solutions. It bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. It also provides post-warranty service contracts for its instruments.
Employees
1,178
Date Price Change Volume
26-09-17 US$76.97 +5.90% 3,142,493
26-09-16 US$72.68 -2.30% 4,082,634
26-09-15 US$74.39 +6.10% 2,905,279
26-09-14 US$70.11 +2.22% 3,364,058
26-09-11 US$68.59 +3.33% 1,829,696
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
76.97USD
Average target price
52.13USD
Spread / Average Target
-32.27%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!